Advertisement

Index by Author

May 1999; 48 (5)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Aiello, L P

    • Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway. Diabetes May 1999 48:1145-1155; doi:10.2337/diabetes.48.5.1145

  2. Aizawa, T

    • cAMP enhances insulin secretion by an action on the ATP-sensitive K+ channel-independent pathway of glucose signaling in rat pancreatic islets. Diabetes May 1999 48:1006-1012; doi:10.2337/diabetes.48.5.1006

  3. Akazawa, S

    • Significance of glutathione-dependent antioxidant system in diabetes-induced embryonic malformations. Diabetes May 1999 48:1138-1144; doi:10.2337/diabetes.48.5.1138

  4. Antoniello, S

    • Splanchnic and leg substrate exchange after ingestion of a natural mixed meal in humans. Diabetes May 1999 48:958-966; doi:10.2337/diabetes.48.5.958

  5. Arai, I

    • Genetic analysis of obese diabetes in the TSOD mouse. Diabetes May 1999 48:1183-1191; doi:10.2337/diabetes.48.5.1183

  6. Aronson, D

    • Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes. Diabetes May 1999 48:1192-1197; doi:10.2337/diabetes.48.5.1192

  7. Auletta, M

    • Splanchnic and leg substrate exchange after ingestion of a natural mixed meal in humans. Diabetes May 1999 48:958-966; doi:10.2337/diabetes.48.5.958

B

  1. Baldwin, A C

    • Increased beta-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse. Diabetes May 1999 48:989-996; doi:10.2337/diabetes.48.5.989

  2. Beattie, G M

    • Sustained proliferation of PDX-1+ cells derived from human islets. Diabetes May 1999 48:1013-1019; doi:10.2337/diabetes.48.5.1013

  3. Bhavsar, S

    • Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta). Diabetes May 1999 48:1026-1034; doi:10.2337/diabetes.48.5.1026

  4. Biolo, G

    • Insulin action on muscle protein kinetics and amino acid transport during recovery after resistance exercise. Diabetes May 1999 48:949-957; doi:10.2337/diabetes.48.5.949

  5. Boden, G

    • Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men. Diabetes May 1999 48:1156-1161; doi:10.2337/diabetes.48.5.1156

  6. Bodkin, N

    • Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta). Diabetes May 1999 48:1026-1034; doi:10.2337/diabetes.48.5.1026

  7. Bossie, S

    • Sustained proliferation of PDX-1+ cells derived from human islets. Diabetes May 1999 48:1013-1019; doi:10.2337/diabetes.48.5.1013

  8. Brechtel, K

    • Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes May 1999 48:1113-1119; doi:10.2337/diabetes.48.5.1113

  9. Broch, M

    • Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy. Diabetes May 1999 48:1108-1112; doi:10.2337/diabetes.48.5.1108

  10. Brooks-Worrell, B M

    • Cellular immune responses to human islet proteins in antibody-positive type 2 diabetic patients. Diabetes May 1999 48:983-988; doi:10.2337/diabetes.48.5.983

  11. Brubaker, P L

    • Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs. Diabetes May 1999 48:1045-1053; doi:10.2337/diabetes.48.5.1045

  12. Brunner, G A

    • Plasma and interstitial glucose dynamics after intravenous glucose injection: evaluation of the single-compartment glucose distribution assumption in the minimal models. Diabetes May 1999 48:1070-1081; doi:10.2337/diabetes.48.5.1070

  13. Busse, R

    • Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes May 1999 48:1131-1137; doi:10.2337/diabetes.48.5.1131

C

  1. Capaldo, B

    • Splanchnic and leg substrate exchange after ingestion of a natural mixed meal in humans. Diabetes May 1999 48:958-966; doi:10.2337/diabetes.48.5.958

  2. Casamitjana, R

    • Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy. Diabetes May 1999 48:1108-1112; doi:10.2337/diabetes.48.5.1108

  3. Chan, C B

    • Beta-cell hypertrophy in fa/fa rats is associated with basal glucose hypersensitivity and reduced SNARE protein expression. Diabetes May 1999 48:997-1005; doi:10.2337/diabetes.48.5.997

  4. Chatterjee, A

    • Endothelin-1 modulates insulin signaling through phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. Diabetes May 1999 48:1120-1130; doi:10.2337/diabetes.48.5.1120

  5. Chen, J L

    • Adenovirus-mediated overexpression of uncoupling protein-2 in pancreatic islets of Zucker diabetic rats increases oxidative activity and improves beta-cell function. Diabetes May 1999 48:1020-1025; doi:10.2337/diabetes.48.5.1020

  6. Chen, X

    • Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men. Diabetes May 1999 48:1156-1161; doi:10.2337/diabetes.48.5.1156

  7. Cherrington, A D

    • Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. Diabetes May 1999 48:1198-1214; doi:10.2337/diabetes.48.5.1198

  8. Chew, S K

    • Isolated low HDL cholesterol: an insulin-resistant state only in the presence of fasting hypertriglyceridemia. Diabetes May 1999 48:1088-1092; doi:10.2337/diabetes.48.5.1088

  9. Chouhan, V

    • Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men. Diabetes May 1999 48:1156-1161; doi:10.2337/diabetes.48.5.1156

  10. Ciociaro, D

    • Splanchnic and leg substrate exchange after ingestion of a natural mixed meal in humans. Diabetes May 1999 48:958-966; doi:10.2337/diabetes.48.5.958

  11. Cirulli, V

    • Sustained proliferation of PDX-1+ cells derived from human islets. Diabetes May 1999 48:1013-1019; doi:10.2337/diabetes.48.5.1013

  12. Claussen, C D

    • Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes May 1999 48:1113-1119; doi:10.2337/diabetes.48.5.1113

D

  1. Dananberg, J

    • Metabolic and hemodynamic effects of moxonidine in the Zucker diabetic fatty rat model of type 2 diabetes. Diabetes May 1999 48:1093-1100; doi:10.2337/diabetes.48.5.1093

  2. Denaro, M

    • Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta). Diabetes May 1999 48:1026-1034; doi:10.2337/diabetes.48.5.1026

  3. Dostou, J M

    • Role of the human kidney in glucose counterregulation. Diabetes May 1999 48:943-948; doi:10.2337/diabetes.48.5.943

E

  1. Efendic, S

    • Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs. Diabetes May 1999 48:1045-1053; doi:10.2337/diabetes.48.5.1045

  2. Elbein, S C

    • A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. Diabetes May 1999 48:1175-1182; doi:10.2337/diabetes.48.5.1175

  3. Ellerman, K E

    • Islet cell membrane antigens activate diabetogenic CD4+ T-cells in the BB/Wor rat. Diabetes May 1999 48:975-982; doi:10.2337/diabetes.48.5.975

  4. Ellmerer, M

    • Plasma and interstitial glucose dynamics after intravenous glucose injection: evaluation of the single-compartment glucose distribution assumption in the minimal models. Diabetes May 1999 48:1070-1081; doi:10.2337/diabetes.48.5.1070

  5. Emmanuel, S C

    • Isolated low HDL cholesterol: an insulin-resistant state only in the presence of fasting hypertriglyceridemia. Diabetes May 1999 48:1088-1092; doi:10.2337/diabetes.48.5.1088

F

  1. Feener, E P

    • Endothelin-1 modulates insulin signaling through phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. Diabetes May 1999 48:1120-1130; doi:10.2337/diabetes.48.5.1120

  2. Fernández-Real, J M

    • Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy. Diabetes May 1999 48:1108-1112; doi:10.2337/diabetes.48.5.1108

  3. Ferrannini, E

    • Splanchnic and leg substrate exchange after ingestion of a natural mixed meal in humans. Diabetes May 1999 48:958-966; doi:10.2337/diabetes.48.5.958

  4. Fleming, R Y

    • Insulin action on muscle protein kinetics and amino acid transport during recovery after resistance exercise. Diabetes May 1999 48:949-957; doi:10.2337/diabetes.48.5.949

  5. Formstecher, P

    • Functional study of the E276Q mutant hepatocyte nuclear factor-4alpha found in type 1 maturity-onset diabetes of the young: impaired synergy with chicken ovalbumin upstream promoter transcription factor II on the hepatocyte nuclear factor-1 promoter. Diabetes May 1999 48:1162-1167; doi:10.2337/diabetes.48.5.1162

  6. Forse, R A

    • Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes. Diabetes May 1999 48:1192-1197; doi:10.2337/diabetes.48.5.1192

  7. Friedman, J E

    • Effects of overexpression of human GLUT4 gene on maternal diabetes and fetal growth in spontaneous gestational diabetic C57BLKS/J Lepr(db/+) mice. Diabetes May 1999 48:1061-1069; doi:10.2337/diabetes.48.5.1061

  8. Fujisawa, T

    • Genetic analysis of late-onset type 2 diabetes in a mouse model of human complex trait. Diabetes May 1999 48:1168-1174; doi:10.2337/diabetes.48.5.1168

G

  1. Gaisano, H Y

    • Beta-cell hypertrophy in fa/fa rats is associated with basal glucose hypersensitivity and reduced SNARE protein expression. Diabetes May 1999 48:997-1005; doi:10.2337/diabetes.48.5.997

  2. Gasa, R

    • Overexpression of G11alpha and isoforms of phospholipase C in islet beta-cells reveals a lack of correlation between inositol phosphate accumulation and insulin secretion. Diabetes May 1999 48:1035-1044; doi:10.2337/diabetes.48.5.1035

  3. Gastaldelli, A

    • Splanchnic and leg substrate exchange after ingestion of a natural mixed meal in humans. Diabetes May 1999 48:958-966; doi:10.2337/diabetes.48.5.958

  4. Gedulin, B R

    • Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta). Diabetes May 1999 48:1026-1034; doi:10.2337/diabetes.48.5.1026

  5. Gerich, J E

    • Role of the human kidney in glucose counterregulation. Diabetes May 1999 48:943-948; doi:10.2337/diabetes.48.5.943

  6. Gervino, E V

    • Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes. Diabetes May 1999 48:1192-1197; doi:10.2337/diabetes.48.5.1192

  7. Giacca, A

    • Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs. Diabetes May 1999 48:1045-1053; doi:10.2337/diabetes.48.5.1045

  8. Gibbs, E M

    • Effects of overexpression of human GLUT4 gene on maternal diabetes and fetal growth in spontaneous gestational diabetic C57BLKS/J Lepr(db/+) mice. Diabetes May 1999 48:1061-1069; doi:10.2337/diabetes.48.5.1061

  9. Gómez-Sáez, J M

    • Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy. Diabetes May 1999 48:1108-1112; doi:10.2337/diabetes.48.5.1108

  10. Goodyear, L J

    • Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes. Diabetes May 1999 48:1192-1197; doi:10.2337/diabetes.48.5.1192

  11. Gordon, E J

    • NOD mice have a generalized defect in their response to transplantation tolerance induction. Diabetes May 1999 48:967-974; doi:10.2337/diabetes.48.5.967

  12. Goto, S

    • Significance of glutathione-dependent antioxidant system in diabetes-induced embryonic malformations. Diabetes May 1999 48:1138-1144; doi:10.2337/diabetes.48.5.1138

  13. Greenbaum, C J

    • Cellular immune responses to human islet proteins in antibody-positive type 2 diabetic patients. Diabetes May 1999 48:983-988; doi:10.2337/diabetes.48.5.983

  14. Greiner, D L

    • NOD mice have a generalized defect in their response to transplantation tolerance induction. Diabetes May 1999 48:967-974; doi:10.2337/diabetes.48.5.967

  15. Guida, R

    • Splanchnic and leg substrate exchange after ingestion of a natural mixed meal in humans. Diabetes May 1999 48:958-966; doi:10.2337/diabetes.48.5.958

  16. Gutiérrez, C

    • Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy. Diabetes May 1999 48:1108-1112; doi:10.2337/diabetes.48.5.1108

H

  1. Hansen, B

    • Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta). Diabetes May 1999 48:1026-1034; doi:10.2337/diabetes.48.5.1026

  2. Hardin, D S

    • Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis. Diabetes May 1999 48:1082-1087; doi:10.2337/diabetes.48.5.1082

  3. Häring, H U

    • Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes May 1999 48:1113-1119; doi:10.2337/diabetes.48.5.1113

  4. Hashizume, K

    • cAMP enhances insulin secretion by an action on the ATP-sensitive K+ channel-independent pathway of glucose signaling in rat pancreatic islets. Diabetes May 1999 48:1006-1012; doi:10.2337/diabetes.48.5.1006

  5. Hasstedt, S J

    • A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. Diabetes May 1999 48:1175-1182; doi:10.2337/diabetes.48.5.1175

  6. Hata, Y

    • Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway. Diabetes May 1999 48:1145-1155; doi:10.2337/diabetes.48.5.1145

  7. Hayashi, H

    • Endogenous glucose production and glucose effectiveness in type 2 diabetic subjects derived from stable-labeled minimal model approach. Diabetes May 1999 48:1054-1060; doi:10.2337/diabetes.48.5.1054

  8. Hayek, A

    • Sustained proliferation of PDX-1+ cells derived from human islets. Diabetes May 1999 48:1013-1019; doi:10.2337/diabetes.48.5.1013

  9. Hemimou, Y

    • Functional study of the E276Q mutant hepatocyte nuclear factor-4alpha found in type 1 maturity-onset diabetes of the young: impaired synergy with chicken ovalbumin upstream promoter transcription factor II on the hepatocyte nuclear factor-1 promoter. Diabetes May 1999 48:1162-1167; doi:10.2337/diabetes.48.5.1162

  10. Higashiyama, M

    • Endogenous glucose production and glucose effectiveness in type 2 diabetic subjects derived from stable-labeled minimal model approach. Diabetes May 1999 48:1054-1060; doi:10.2337/diabetes.48.5.1054

  11. Hirayama, I

    • Genetic analysis of obese diabetes in the TSOD mouse. Diabetes May 1999 48:1183-1191; doi:10.2337/diabetes.48.5.1183

  12. Hirshman, M F

    • Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes. Diabetes May 1999 48:1192-1197; doi:10.2337/diabetes.48.5.1192

  13. Hoenig, S J

    • Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes. Diabetes May 1999 48:1192-1197; doi:10.2337/diabetes.48.5.1192

  14. Hoffman, M D

    • A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. Diabetes May 1999 48:1175-1182; doi:10.2337/diabetes.48.5.1175

  15. Horton, E S

    • Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes. Diabetes May 1999 48:1192-1197; doi:10.2337/diabetes.48.5.1192

I

  1. Ikegami, H

    • Genetic analysis of late-onset type 2 diabetes in a mouse model of human complex trait. Diabetes May 1999 48:1168-1174; doi:10.2337/diabetes.48.5.1168

  2. Irwin, D M

    • Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs. Diabetes May 1999 48:1045-1053; doi:10.2337/diabetes.48.5.1045

  3. Ishibashi, M

    • Significance of glutathione-dependent antioxidant system in diabetes-induced embryonic malformations. Diabetes May 1999 48:1138-1144; doi:10.2337/diabetes.48.5.1138

  4. Ishikawa, S

    • Endogenous glucose production and glucose effectiveness in type 2 diabetic subjects derived from stable-labeled minimal model approach. Diabetes May 1999 48:1054-1060; doi:10.2337/diabetes.48.5.1054

  5. Ishizuka, T

    • Effects of overexpression of human GLUT4 gene on maternal diabetes and fetal growth in spontaneous gestational diabetic C57BLKS/J Lepr(db/+) mice. Diabetes May 1999 48:1061-1069; doi:10.2337/diabetes.48.5.1061

  6. Itkin-Ansari, P

    • Sustained proliferation of PDX-1+ cells derived from human islets. Diabetes May 1999 48:1013-1019; doi:10.2337/diabetes.48.5.1013

  7. Izumino, K

    • Significance of glutathione-dependent antioxidant system in diabetes-induced embryonic malformations. Diabetes May 1999 48:1138-1144; doi:10.2337/diabetes.48.5.1138

  8. Izumi, S

    • Genetic analysis of obese diabetes in the TSOD mouse. Diabetes May 1999 48:1183-1191; doi:10.2337/diabetes.48.5.1183

  9. Izumi, T

    • Genetic analysis of obese diabetes in the TSOD mouse. Diabetes May 1999 48:1183-1191; doi:10.2337/diabetes.48.5.1183

J

  1. Jacob, S

    • Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes May 1999 48:1113-1119; doi:10.2337/diabetes.48.5.1113

  2. Jiang, Z Y

    • Endothelin-1 modulates insulin signaling through phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. Diabetes May 1999 48:1120-1130; doi:10.2337/diabetes.48.5.1120

  3. Jodka, C

    • Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta). Diabetes May 1999 48:1026-1034; doi:10.2337/diabetes.48.5.1026

  4. Johnson, W T

    • Metabolic and hemodynamic effects of moxonidine in the Zucker diabetic fatty rat model of type 2 diabetes. Diabetes May 1999 48:1093-1100; doi:10.2337/diabetes.48.5.1093

  5. Juneja, R

    • Cellular immune responses to human islet proteins in antibody-positive type 2 diabetic patients. Diabetes May 1999 48:983-988; doi:10.2337/diabetes.48.5.983

K

  1. Kaneko, T

    • cAMP enhances insulin secretion by an action on the ATP-sensitive K+ channel-independent pathway of glucose signaling in rat pancreatic islets. Diabetes May 1999 48:1006-1012; doi:10.2337/diabetes.48.5.1006

  2. Kawaguchi, Y

    • Genetic analysis of late-onset type 2 diabetes in a mouse model of human complex trait. Diabetes May 1999 48:1168-1174; doi:10.2337/diabetes.48.5.1168

  3. Kawakami, A

    • Endogenous glucose production and glucose effectiveness in type 2 diabetic subjects derived from stable-labeled minimal model approach. Diabetes May 1999 48:1054-1060; doi:10.2337/diabetes.48.5.1054

  4. Kennedy, J W

    • Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes. Diabetes May 1999 48:1192-1197; doi:10.2337/diabetes.48.5.1192

  5. King, G L

    • Endothelin-1 modulates insulin signaling through phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. Diabetes May 1999 48:1120-1130; doi:10.2337/diabetes.48.5.1120

  6. Klepcyk, P

    • Effects of overexpression of human GLUT4 gene on maternal diabetes and fetal growth in spontaneous gestational diabetic C57BLKS/J Lepr(db/+) mice. Diabetes May 1999 48:1061-1069; doi:10.2337/diabetes.48.5.1061

  7. Komatsu, M

    • cAMP enhances insulin secretion by an action on the ATP-sensitive K+ channel-independent pathway of glucose signaling in rat pancreatic islets. Diabetes May 1999 48:1006-1012; doi:10.2337/diabetes.48.5.1006

  8. Kondo, T

    • Significance of glutathione-dependent antioxidant system in diabetes-induced embryonic malformations. Diabetes May 1999 48:1138-1144; doi:10.2337/diabetes.48.5.1138

  9. Kusaka, I

    • Endogenous glucose production and glucose effectiveness in type 2 diabetic subjects derived from stable-labeled minimal model approach. Diabetes May 1999 48:1054-1060; doi:10.2337/diabetes.48.5.1054

  10. Kuwano, H

    • Genetic analysis of obese diabetes in the TSOD mouse. Diabetes May 1999 48:1183-1191; doi:10.2337/diabetes.48.5.1183

L

  1. Laakso, M

    • Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes May 1999 48:937-942; doi:10.2337/diabetes.48.5.937

  2. Laine, B

    • Functional study of the E276Q mutant hepatocyte nuclear factor-4alpha found in type 1 maturity-onset diabetes of the young: impaired synergy with chicken ovalbumin upstream promoter transcription factor II on the hepatocyte nuclear factor-1 promoter. Diabetes May 1999 48:1162-1167; doi:10.2337/diabetes.48.5.1162

  3. LeBlanc, A

    • Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis. Diabetes May 1999 48:1082-1087; doi:10.2337/diabetes.48.5.1082

  4. Lee, Y

    • Adenovirus-mediated overexpression of uncoupling protein-2 in pancreatic islets of Zucker diabetic rats increases oxidative activity and improves beta-cell function. Diabetes May 1999 48:1020-1025; doi:10.2337/diabetes.48.5.1020

  5. Leibowitz, G

    • Sustained proliferation of PDX-1+ cells derived from human islets. Diabetes May 1999 48:1013-1019; doi:10.2337/diabetes.48.5.1013

  6. Leis, H J

    • Plasma and interstitial glucose dynamics after intravenous glucose injection: evaluation of the single-compartment glucose distribution assumption in the minimal models. Diabetes May 1999 48:1070-1081; doi:10.2337/diabetes.48.5.1070

  7. Leppert, M F

    • A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. Diabetes May 1999 48:1175-1182; doi:10.2337/diabetes.48.5.1175

  8. Levine, F

    • Sustained proliferation of PDX-1+ cells derived from human islets. Diabetes May 1999 48:1013-1019; doi:10.2337/diabetes.48.5.1013

  9. Levisetti, M

    • Increased beta-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse. Diabetes May 1999 48:989-996; doi:10.2337/diabetes.48.5.989

  10. Like, A A

    • Islet cell membrane antigens activate diabetogenic CD4+ T-cells in the BB/Wor rat. Diabetes May 1999 48:975-982; doi:10.2337/diabetes.48.5.975

  11. Liu, S

    • Effects of overexpression of human GLUT4 gene on maternal diabetes and fetal growth in spontaneous gestational diabetic C57BLKS/J Lepr(db/+) mice. Diabetes May 1999 48:1061-1069; doi:10.2337/diabetes.48.5.1061

  12. Lopez, A D

    • Sustained proliferation of PDX-1+ cells derived from human islets. Diabetes May 1999 48:1013-1019; doi:10.2337/diabetes.48.5.1013

M

  1. MacDonald, P E

    • Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs. Diabetes May 1999 48:1045-1053; doi:10.2337/diabetes.48.5.1045

  2. Machann, J

    • Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes May 1999 48:1113-1119; doi:10.2337/diabetes.48.5.1113

  3. MacPhail, R M

    • Beta-cell hypertrophy in fa/fa rats is associated with basal glucose hypersensitivity and reduced SNARE protein expression. Diabetes May 1999 48:997-1005; doi:10.2337/diabetes.48.5.997

  4. Maerker, E

    • Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes May 1999 48:1113-1119; doi:10.2337/diabetes.48.5.1113

  5. Mally, M I

    • Sustained proliferation of PDX-1+ cells derived from human islets. Diabetes May 1999 48:1013-1019; doi:10.2337/diabetes.48.5.1013

  6. Markees, T G

    • NOD mice have a generalized defect in their response to transplantation tolerance induction. Diabetes May 1999 48:967-974; doi:10.2337/diabetes.48.5.967

  7. Marumo, T

    • Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes May 1999 48:1131-1137; doi:10.2337/diabetes.48.5.1131

  8. Matthaei, S

    • Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes May 1999 48:1113-1119; doi:10.2337/diabetes.48.5.1113

  9. McCall, R H

    • Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs. Diabetes May 1999 48:1045-1053; doi:10.2337/diabetes.48.5.1045

  10. Meyer, C

    • Role of the human kidney in glucose counterregulation. Diabetes May 1999 48:943-948; doi:10.2337/diabetes.48.5.943

  11. Minokadeh, A

    • Cellular immune responses to human islet proteins in antibody-positive type 2 diabetic patients. Diabetes May 1999 48:983-988; doi:10.2337/diabetes.48.5.983

  12. Molina, A

    • Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy. Diabetes May 1999 48:1108-1112; doi:10.2337/diabetes.48.5.1108

  13. Mordes, J P

    • NOD mice have a generalized defect in their response to transplantation tolerance induction. Diabetes May 1999 48:967-974; doi:10.2337/diabetes.48.5.967

  14. Myers, M G, Jr

    • Endothelin-1 modulates insulin signaling through phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. Diabetes May 1999 48:1120-1130; doi:10.2337/diabetes.48.5.1120

N

  1. Nagai, M

    • cAMP enhances insulin secretion by an action on the ATP-sensitive K+ channel-independent pathway of glucose signaling in rat pancreatic islets. Diabetes May 1999 48:1006-1012; doi:10.2337/diabetes.48.5.1006

  2. Nagamachi, Y

    • Genetic analysis of obese diabetes in the TSOD mouse. Diabetes May 1999 48:1183-1191; doi:10.2337/diabetes.48.5.1183

  3. Nagasaka, S

    • Endogenous glucose production and glucose effectiveness in type 2 diabetic subjects derived from stable-labeled minimal model approach. Diabetes May 1999 48:1054-1060; doi:10.2337/diabetes.48.5.1054

  4. Nagataki, S

    • Significance of glutathione-dependent antioxidant system in diabetes-induced embryonic malformations. Diabetes May 1999 48:1138-1144; doi:10.2337/diabetes.48.5.1138

  5. Nakamura, T

    • Endogenous glucose production and glucose effectiveness in type 2 diabetic subjects derived from stable-labeled minimal model approach. Diabetes May 1999 48:1054-1060; doi:10.2337/diabetes.48.5.1054

  6. Newgard, C B

    • Adenovirus-mediated overexpression of uncoupling protein-2 in pancreatic islets of Zucker diabetic rats increases oxidative activity and improves beta-cell function. Diabetes May 1999 48:1020-1025; doi:10.2337/diabetes.48.5.1020
    • Overexpression of G11alpha and isoforms of phospholipase C in islet beta-cells reveals a lack of correlation between inositol phosphate accumulation and insulin secretion. Diabetes May 1999 48:1035-1044; doi:10.2337/diabetes.48.5.1035

  7. Noelle, R J

    • NOD mice have a generalized defect in their response to transplantation tolerance induction. Diabetes May 1999 48:967-974; doi:10.2337/diabetes.48.5.967

O

  1. Ocel, J V

    • Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes. Diabetes May 1999 48:1192-1197; doi:10.2337/diabetes.48.5.1192

  2. Ogihara, T

    • Genetic analysis of late-onset type 2 diabetes in a mouse model of human complex trait. Diabetes May 1999 48:1168-1174; doi:10.2337/diabetes.48.5.1168

P

  1. Palmer, J P

    • Cellular immune responses to human islet proteins in antibody-positive type 2 diabetic patients. Diabetes May 1999 48:983-988; doi:10.2337/diabetes.48.5.983

  2. Panko, L

    • Effects of overexpression of human GLUT4 gene on maternal diabetes and fetal growth in spontaneous gestational diabetic C57BLKS/J Lepr(db/+) mice. Diabetes May 1999 48:1061-1069; doi:10.2337/diabetes.48.5.1061

  3. Para, L

    • Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis. Diabetes May 1999 48:1082-1087; doi:10.2337/diabetes.48.5.1082

  4. Pardo, F

    • Splanchnic and leg substrate exchange after ingestion of a natural mixed meal in humans. Diabetes May 1999 48:958-966; doi:10.2337/diabetes.48.5.958

  5. Phillips, N E

    • NOD mice have a generalized defect in their response to transplantation tolerance induction. Diabetes May 1999 48:967-974; doi:10.2337/diabetes.48.5.967

  6. Pick, A J

    • Increased beta-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse. Diabetes May 1999 48:989-996; doi:10.2337/diabetes.48.5.989

  7. Pieber, T R

    • Plasma and interstitial glucose dynamics after intravenous glucose injection: evaluation of the single-compartment glucose distribution assumption in the minimal models. Diabetes May 1999 48:1070-1081; doi:10.2337/diabetes.48.5.1070

  8. Polonsky, K S

    • Increased beta-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse. Diabetes May 1999 48:989-996; doi:10.2337/diabetes.48.5.989

  9. Pugh, W

    • Increased beta-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse. Diabetes May 1999 48:989-996; doi:10.2337/diabetes.48.5.989

R

  1. Rao, A K

    • Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men. Diabetes May 1999 48:1156-1161; doi:10.2337/diabetes.48.5.1156

  2. Rashid, S

    • Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs. Diabetes May 1999 48:1045-1053; doi:10.2337/diabetes.48.5.1045

  3. Regittnig, W

    • Plasma and interstitial glucose dynamics after intravenous glucose injection: evaluation of the single-compartment glucose distribution assumption in the minimal models. Diabetes May 1999 48:1070-1081; doi:10.2337/diabetes.48.5.1070

  4. Renn, W

    • Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes May 1999 48:1113-1119; doi:10.2337/diabetes.48.5.1113

  5. Rett, K

    • Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes May 1999 48:1113-1119; doi:10.2337/diabetes.48.5.1113

  6. Ricart, W

    • Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy. Diabetes May 1999 48:1108-1112; doi:10.2337/diabetes.48.5.1108

  7. Rokkaku, K

    • Endogenous glucose production and glucose effectiveness in type 2 diabetic subjects derived from stable-labeled minimal model approach. Diabetes May 1999 48:1054-1060; doi:10.2337/diabetes.48.5.1054

  8. Rook, S L

    • Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway. Diabetes May 1999 48:1145-1155; doi:10.2337/diabetes.48.5.1145

  9. Rossini, A A

    • NOD mice have a generalized defect in their response to transplantation tolerance induction. Diabetes May 1999 48:967-974; doi:10.2337/diabetes.48.5.967

S

  1. Saccà, L

    • Splanchnic and leg substrate exchange after ingestion of a natural mixed meal in humans. Diabetes May 1999 48:958-966; doi:10.2337/diabetes.48.5.958

  2. Saito, T

    • Endogenous glucose production and glucose effectiveness in type 2 diabetic subjects derived from stable-labeled minimal model approach. Diabetes May 1999 48:1054-1060; doi:10.2337/diabetes.48.5.1054

  3. Sakamaki, H

    • Significance of glutathione-dependent antioxidant system in diabetes-induced embryonic malformations. Diabetes May 1999 48:1138-1144; doi:10.2337/diabetes.48.5.1138

  4. Sandhu, H

    • Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs. Diabetes May 1999 48:1045-1053; doi:10.2337/diabetes.48.5.1045

  5. Satkunarajah, M

    • Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs. Diabetes May 1999 48:1045-1053; doi:10.2337/diabetes.48.5.1045

  6. Schaupp, L

    • Plasma and interstitial glucose dynamics after intravenous glucose injection: evaluation of the single-compartment glucose distribution assumption in the minimal models. Diabetes May 1999 48:1070-1081; doi:10.2337/diabetes.48.5.1070

  7. Schermerhorn, T

    • cAMP enhances insulin secretion by an action on the ATP-sensitive K+ channel-independent pathway of glucose signaling in rat pancreatic islets. Diabetes May 1999 48:1006-1012; doi:10.2337/diabetes.48.5.1006

  8. Schick, F

    • Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes May 1999 48:1113-1119; doi:10.2337/diabetes.48.5.1113

  9. Schini-Kerth, V B

    • Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes May 1999 48:1131-1137; doi:10.2337/diabetes.48.5.1131

  10. Seilheimer, D K

    • Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis. Diabetes May 1999 48:1082-1087; doi:10.2337/diabetes.48.5.1082

  11. Sendlhofer, G

    • Plasma and interstitial glucose dynamics after intravenous glucose injection: evaluation of the single-compartment glucose distribution assumption in the minimal models. Diabetes May 1999 48:1070-1081; doi:10.2337/diabetes.48.5.1070

  12. Serreze, D V

    • NOD mice have a generalized defect in their response to transplantation tolerance induction. Diabetes May 1999 48:967-974; doi:10.2337/diabetes.48.5.967

  13. Sharp, G W

    • cAMP enhances insulin secretion by an action on the ATP-sensitive K+ channel-independent pathway of glucose signaling in rat pancreatic islets. Diabetes May 1999 48:1006-1012; doi:10.2337/diabetes.48.5.1006

  14. Sheu, L

    • Beta-cell hypertrophy in fa/fa rats is associated with basal glucose hypersensitivity and reduced SNARE protein expression. Diabetes May 1999 48:997-1005; doi:10.2337/diabetes.48.5.997

  15. Shibata, M

    • Genetic analysis of late-onset type 2 diabetes in a mouse model of human complex trait. Diabetes May 1999 48:1168-1174; doi:10.2337/diabetes.48.5.1168

  16. Shimabukuro, M

    • Adenovirus-mediated overexpression of uncoupling protein-2 in pancreatic islets of Zucker diabetic rats increases oxidative activity and improves beta-cell function. Diabetes May 1999 48:1020-1025; doi:10.2337/diabetes.48.5.1020

  17. Shi, Z Q

    • Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs. Diabetes May 1999 48:1045-1053; doi:10.2337/diabetes.48.5.1045

  18. Shultz, L D

    • NOD mice have a generalized defect in their response to transplantation tolerance induction. Diabetes May 1999 48:967-974; doi:10.2337/diabetes.48.5.967

  19. Soler, J

    • Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy. Diabetes May 1999 48:1108-1112; doi:10.2337/diabetes.48.5.1108

  20. Sorli, C H

    • NOD mice have a generalized defect in their response to transplantation tolerance induction. Diabetes May 1999 48:967-974; doi:10.2337/diabetes.48.5.967

  21. Sreenan, S

    • Increased beta-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse. Diabetes May 1999 48:989-996; doi:10.2337/diabetes.48.5.989

  22. Steinberg, M I

    • Metabolic and hemodynamic effects of moxonidine in the Zucker diabetic fatty rat model of type 2 diabetes. Diabetes May 1999 48:1093-1100; doi:10.2337/diabetes.48.5.1093

  23. Suaud, L

    • Functional study of the E276Q mutant hepatocyte nuclear factor-4alpha found in type 1 maturity-onset diabetes of the young: impaired synergy with chicken ovalbumin upstream promoter transcription factor II on the hepatocyte nuclear factor-1 promoter. Diabetes May 1999 48:1162-1167; doi:10.2337/diabetes.48.5.1162

  24. Sun, L

    • Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men. Diabetes May 1999 48:1156-1161; doi:10.2337/diabetes.48.5.1156

  25. Suzuki, W

    • Genetic analysis of obese diabetes in the TSOD mouse. Diabetes May 1999 48:1183-1191; doi:10.2337/diabetes.48.5.1183

T

  1. Tai, E S

    • Isolated low HDL cholesterol: an insulin-resistant state only in the presence of fasting hypertriglyceridemia. Diabetes May 1999 48:1088-1092; doi:10.2337/diabetes.48.5.1088

  2. Takeuchi, T

    • Genetic analysis of obese diabetes in the TSOD mouse. Diabetes May 1999 48:1183-1191; doi:10.2337/diabetes.48.5.1183

  3. Takino, H

    • Significance of glutathione-dependent antioxidant system in diabetes-induced embryonic malformations. Diabetes May 1999 48:1138-1144; doi:10.2337/diabetes.48.5.1138

  4. Tan, B Y

    • Isolated low HDL cholesterol: an insulin-resistant state only in the presence of fasting hypertriglyceridemia. Diabetes May 1999 48:1088-1092; doi:10.2337/diabetes.48.5.1088

  5. Tan, C E

    • Isolated low HDL cholesterol: an insulin-resistant state only in the presence of fasting hypertriglyceridemia. Diabetes May 1999 48:1088-1092; doi:10.2337/diabetes.48.5.1088

  6. Tchipashvili, V

    • Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs. Diabetes May 1999 48:1045-1053; doi:10.2337/diabetes.48.5.1045

  7. Teng, K

    • A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. Diabetes May 1999 48:1175-1182; doi:10.2337/diabetes.48.5.1175

  8. Tokuyama, K

    • Endogenous glucose production and glucose effectiveness in type 2 diabetic subjects derived from stable-labeled minimal model approach. Diabetes May 1999 48:1054-1060; doi:10.2337/diabetes.48.5.1054

  9. Trajanoski, Z

    • Plasma and interstitial glucose dynamics after intravenous glucose injection: evaluation of the single-compartment glucose distribution assumption in the minimal models. Diabetes May 1999 48:1070-1081; doi:10.2337/diabetes.48.5.1070

  10. Trinh, K Y

    • Adenovirus-mediated overexpression of uncoupling protein-2 in pancreatic islets of Zucker diabetic rats increases oxidative activity and improves beta-cell function. Diabetes May 1999 48:1020-1025; doi:10.2337/diabetes.48.5.1020
    • Overexpression of G11alpha and isoforms of phospholipase C in islet beta-cells reveals a lack of correlation between inositol phosphate accumulation and insulin secretion. Diabetes May 1999 48:1035-1044; doi:10.2337/diabetes.48.5.1035

U

  1. Ueda, H

    • Genetic analysis of late-onset type 2 diabetes in a mouse model of human complex trait. Diabetes May 1999 48:1168-1174; doi:10.2337/diabetes.48.5.1168

  2. Unger, R H

    • Adenovirus-mediated overexpression of uncoupling protein-2 in pancreatic islets of Zucker diabetic rats increases oxidative activity and improves beta-cell function. Diabetes May 1999 48:1020-1025; doi:10.2337/diabetes.48.5.1020

  3. Urata, Y

    • Significance of glutathione-dependent antioxidant system in diabetes-induced embryonic malformations. Diabetes May 1999 48:1138-1144; doi:10.2337/diabetes.48.5.1138

V

  1. Vendrell, J

    • Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy. Diabetes May 1999 48:1108-1112; doi:10.2337/diabetes.48.5.1108

  2. Virkamäki, A

    • Allosteric regulation of glycogen synthase and hexokinase by glucosamine-6-phosphate during glucosamine-induced insulin resistance in skeletal muscle and heart. Diabetes May 1999 48:1101-1107; doi:10.2337/diabetes.48.5.1101

  3. Volk, A

    • Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes May 1999 48:1113-1119; doi:10.2337/diabetes.48.5.1113

  4. Vranic, M

    • Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs. Diabetes May 1999 48:1045-1053; doi:10.2337/diabetes.48.5.1045

W

  1. Wach, P

    • Plasma and interstitial glucose dynamics after intravenous glucose injection: evaluation of the single-compartment glucose distribution assumption in the minimal models. Diabetes May 1999 48:1070-1081; doi:10.2337/diabetes.48.5.1070

  2. Wang, M Y

    • Adenovirus-mediated overexpression of uncoupling protein-2 in pancreatic islets of Zucker diabetic rats increases oxidative activity and improves beta-cell function. Diabetes May 1999 48:1020-1025; doi:10.2337/diabetes.48.5.1020

  3. Wheeler, M B

    • Beta-cell hypertrophy in fa/fa rats is associated with basal glucose hypersensitivity and reduced SNARE protein expression. Diabetes May 1999 48:997-1005; doi:10.2337/diabetes.48.5.997
    • Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs. Diabetes May 1999 48:1045-1053; doi:10.2337/diabetes.48.5.1045

  4. White, M F

    • Endothelin-1 modulates insulin signaling through phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. Diabetes May 1999 48:1120-1130; doi:10.2337/diabetes.48.5.1120

  5. Wiesenthal, S R

    • Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs. Diabetes May 1999 48:1045-1053; doi:10.2337/diabetes.48.5.1045

  6. Wilkie, T M

    • Overexpression of G11alpha and isoforms of phospholipase C in islet beta-cells reveals a lack of correlation between inositol phosphate accumulation and insulin secretion. Diabetes May 1999 48:1035-1044; doi:10.2337/diabetes.48.5.1035

  7. Williams, B D

    • Insulin action on muscle protein kinetics and amino acid transport during recovery after resistance exercise. Diabetes May 1999 48:949-957; doi:10.2337/diabetes.48.5.949

  8. Woda, B A

    • NOD mice have a generalized defect in their response to transplantation tolerance induction. Diabetes May 1999 48:967-974; doi:10.2337/diabetes.48.5.967

  9. Wolfe, R R

    • Insulin action on muscle protein kinetics and amino acid transport during recovery after resistance exercise. Diabetes May 1999 48:949-957; doi:10.2337/diabetes.48.5.949

  10. Wutte, A

    • Plasma and interstitial glucose dynamics after intravenous glucose injection: evaluation of the single-compartment glucose distribution assumption in the minimal models. Diabetes May 1999 48:1070-1081; doi:10.2337/diabetes.48.5.1070

Y

  1. Yajima, H

    • cAMP enhances insulin secretion by an action on the ATP-sensitive K+ channel-independent pathway of glucose signaling in rat pancreatic islets. Diabetes May 1999 48:1006-1012; doi:10.2337/diabetes.48.5.1006

  2. Yakubu-Madus, F E

    • Metabolic and hemodynamic effects of moxonidine in the Zucker diabetic fatty rat model of type 2 diabetes. Diabetes May 1999 48:1093-1100; doi:10.2337/diabetes.48.5.1093

  3. Yamaguchi, Y

    • Significance of glutathione-dependent antioxidant system in diabetes-induced embryonic malformations. Diabetes May 1999 48:1138-1144; doi:10.2337/diabetes.48.5.1138

  4. Yamasaki, H

    • Significance of glutathione-dependent antioxidant system in diabetes-induced embryonic malformations. Diabetes May 1999 48:1138-1144; doi:10.2337/diabetes.48.5.1138

  5. Yamato, E

    • Genetic analysis of late-onset type 2 diabetes in a mouse model of human complex trait. Diabetes May 1999 48:1168-1174; doi:10.2337/diabetes.48.5.1168

  6. Yi, Z

    • Genetic analysis of obese diabetes in the TSOD mouse. Diabetes May 1999 48:1183-1191; doi:10.2337/diabetes.48.5.1183

  7. Yki-Järvinen, H

    • Allosteric regulation of glycogen synthase and hexokinase by glucosamine-6-phosphate during glucosamine-induced insulin resistance in skeletal muscle and heart. Diabetes May 1999 48:1101-1107; doi:10.2337/diabetes.48.5.1101

  8. Young, A A

    • Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta). Diabetes May 1999 48:1026-1034; doi:10.2337/diabetes.48.5.1026

  9. Yu, K

    • Overexpression of G11alpha and isoforms of phospholipase C in islet beta-cells reveals a lack of correlation between inositol phosphate accumulation and insulin secretion. Diabetes May 1999 48:1035-1044; doi:10.2337/diabetes.48.5.1035

Z

  1. Zhou, Q L

    • Endothelin-1 modulates insulin signaling through phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. Diabetes May 1999 48:1120-1130; doi:10.2337/diabetes.48.5.1120

  2. Zimmerman, K M

    • Metabolic and hemodynamic effects of moxonidine in the Zucker diabetic fatty rat model of type 2 diabetes. Diabetes May 1999 48:1093-1100; doi:10.2337/diabetes.48.5.1093

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement